{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:29:42Z","timestamp":1778887782854,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Sexually transmitted infections (STIs) are hypothesized to play a role in the development of prostate cancer, perhaps due to inflammation-induced oncogenesis. We assessed in a nationally representative population of middle-aged men whether sexual behavior indicators for an increased risk of genital infection were associated with serum prostate-specific antigen (PSA) concentration, a marker of prostatic disease and inflammation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The percentage of men between the ages of 40 and 59 with a PSA \u2265 4.0 ng\/ml was 2.6% (95% confidence interval [CI], 1.8% \u2013 3.8%). The percentage of men between the ages of 40 and 59 self-reporting a past diagnosis of genital warts or genital herpes, or a recent diagnosis of gonorrhea or chlamydia is estimated to be 7.3% (95% CI, 6.2% \u2013 8.6%). Men self-reporting that they had had sex without using a condom in the past month had a lower PSA concentration and higher %fPSA than those who did not. There were no associations between any of the other sexual activity or laboratory measures and PSA or %fPSA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>In this nationally representative sample of middle-aged American men, we did not find consistent evidence for an association between sexual behavior or a history of STIs and PSA levels. Therefore, sexual factors are unlikely to lead to falsely elevated PSA tests in this population. We cannot rule out the role of these factors in causing false positive PSA tests in subgroups of the population that have a higher prevalence of high-risk sexual behavior, and more protracted or recent exposures to these agents.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1750-9378-2-19","type":"journal-article","created":{"date-parts":[[2007,10,24]],"date-time":"2007-10-24T16:40:09Z","timestamp":1193244009000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prostate-specific antigen, sexual behavior, and sexually transmitted infections in US men 40\u201359 years old, 2001\u20132004: a cross \u2013 sectional study"],"prefix":"10.1186","volume":"2","author":[{"given":"David M","family":"Werny","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Saraiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A","family":"Platz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,10,24]]},"reference":[{"key":"28_CR1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/00001648-200201000-00012","volume":"13","author":"LK Dennis","year":"2002","unstructured":"Dennis LK, Dawson DV: Meta-analysis of measures of sexual activity and prostate cancer. Epidemiology. 2002, 13: 72-10.1097\/00001648-200201000-00012.","journal-title":"Epidemiology"},{"key":"28_CR2","first-page":"506","volume":"37","author":"ML Taylor","year":"2005","unstructured":"Taylor ML, Mainous AG, Wells BJ: Prostate cancer and sexually transmitted diseases: a meta-analysis. Fam Med. 2005, 37: 506-","journal-title":"Fam Med"},{"key":"28_CR3","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1097\/01.ju.0000108131.43160.77","volume":"171","author":"EA Platz","year":"2004","unstructured":"Platz EA, De Marzo AM: Epidemiology of inflammation and prostate cancer. J Urol. 2004, 171: S36-10.1097\/01.ju.0000108131.43160.77.","journal-title":"J Urol"},{"key":"28_CR4","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.ypmed.2004.01.005","volume":"38","author":"LE Ross","year":"2004","unstructured":"Ross LE, Coates RJ, Breen N, Uhler RJ, Potosky AL, Blackman D: Prostate-specific antigen test use reported in the 2000 National Health Interview Survey. Prev Med. 2004, 38: 732-10.1016\/j.ypmed.2004.01.005.","journal-title":"Prev Med"},{"key":"28_CR5","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1002\/cncr.20856","volume":"103","author":"J Baillargeon","year":"2005","unstructured":"Baillargeon J, Pollock BH, Kristal AR, Bradshaw P, Hernandez J, Basler J, Higgins B, Lynch S: The association of body mass index and prostate-specific antigen in a population-based study. Cancer. 2005, 103: 1092-10.1002\/cncr.20856.","journal-title":"Cancer"},{"key":"28_CR6","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1056\/NEJM199608013350502","volume":"335","author":"TO Morgan","year":"1996","unstructured":"Morgan TO, Jacobsen SJ, McCarthy WF, Jacobson DJ, McLeod DG, Moul JW: Age-specific reference ranges for prostate-specific antigen in black men. N Engl J Med. 1996, 335: 304-10.1056\/NEJM199608013350502.","journal-title":"N Engl J Med"},{"key":"28_CR7","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1001\/jama.1995.03530150038031","volume":"274","author":"WJ Catalona","year":"1995","unstructured":"Catalona WJ, Smith DS, Wolfert RL, Wang TJ, Rittenhouse HG, Ratliff TL, Nadler RB: Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA. 1995, 274: 1214-10.1001\/jama.274.15.1214.","journal-title":"JAMA"},{"key":"28_CR8","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S0302-2838(03)00158-1","volume":"43","author":"X Game","year":"2003","unstructured":"Game X, Vincendeau S, Palascak R, Milcent S, Fournier R, Houlgatte A: Total and Free Serum Prostate Specific Antigen Levels during the First Month of Acute Prostatitis. Eur Urol. 2003, 43: 702-10.1016\/S0302-2838(03)00158-1.","journal-title":"Eur Urol"},{"key":"28_CR9","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0022-5347(01)64957-7","volume":"157","author":"J Irani","year":"1997","unstructured":"Irani J, Levillain P, Goujon JM, Bon D, Dore B, Aubert J: Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value. J Urol. 1997, 157: 1301-10.1016\/S0022-5347(01)64957-7.","journal-title":"J Urol"},{"key":"28_CR10","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1159\/000020161","volume":"37","author":"PH Schatteman","year":"2000","unstructured":"Schatteman PH, Hoekx L, Wyndaele JJ, Jeuris W, Van ME: Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density. Eur Urol. 2000, 37: 404-10.1159\/000020161.","journal-title":"Eur Urol"},{"key":"28_CR11","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/sj.pcan.4500535","volume":"4","author":"JC Oliver","year":"2001","unstructured":"Oliver JC, Oliver RT, Ballard RC: Influence of circumcision and sexual behaviour on PSA levels in patients attending a sexually transmitted disease (STD) clinic. Prostate Cancer Prostatic Dis. 2001, 4: 228-10.1038\/sj.pcan.4500535.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"28_CR12","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1016\/S0022-5347(05)00892-X","volume":"175","author":"S Sutcliffe","year":"2006","unstructured":"Sutcliffe S, Zenilman JM, Ghanem KG, Jadack RA, Sokoll LJ, Elliott DJ, Nelson WG, DeMarzo AM, Cole SR, Isaacs WB, Platz EA: Sexually transmitted infections and prostatic inflammation\/cell damage as measured by serum prostate specific antigen concentration. J Urol. 2006, 175: 1937-10.1016\/S0022-5347(05)00892-X.","journal-title":"J Urol"},{"key":"28_CR13","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1136\/bmj.309.6965.1325","volume":"309","author":"FM Cowan","year":"1994","unstructured":"Cowan FM, Johnson AM, Ashley R, Corey L, Mindel A: Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. BMJ, %19. 1994, 309: 1325-","journal-title":"BMJ, %19"},{"key":"28_CR14","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1158\/1055-9965.EPI-05-0206","volume":"14","author":"M Saraiya","year":"2005","unstructured":"Saraiya M, Kottiri BJ, Leadbetter S, Blackman D, Thompson T, McKenna MT, Stallings FL: Total and percent free prostate-specific antigen levels among U.S. men, 2001\u20132002. Cancer EpidemiolBiomarkers Prev. 2005, 14: 2178-10.1158\/1055-9965.EPI-05-0206.","journal-title":"Cancer EpidemiolBiomarkers Prev"},{"key":"28_CR15","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S0302-2838(03)00158-1","volume":"43","author":"X Game","year":"2003","unstructured":"Game X, Vincendeau S, Palascak R, Milcent S, Fournier R, Houlgatte A: Total and Free Serum Prostate Specific Antigen Levels during the First Month of Acute Prostatitis. Eur Urol. 2003, 43: 702-10.1016\/S0302-2838(03)00158-1.","journal-title":"Eur Urol"},{"key":"28_CR16","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1097\/01.ju.0000177470.84735.55","volume":"174","author":"BR Konety","year":"2005","unstructured":"Konety BR, Bird VY, Deorah S, Dahmoush L: Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era. J Urol. 2005, 174: 1785-10.1097\/01.ju.0000177470.84735.55.","journal-title":"J Urol"},{"key":"28_CR17","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1464-410X.1993.tb15990.x","volume":"71","author":"GN Collins","year":"1993","unstructured":"Collins GN, Lee RJ, McKelvie GB, Rogers AC, Hehir M: Relationship between prostate specific antigen, prostate volume and age in the benign prostate. Br J Urol. 1993, 71: 445-","journal-title":"Br J Urol"},{"key":"28_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1207\/S15324796ABM2602_03","volume":"26","author":"KE Schroder","year":"2003","unstructured":"Schroder KE, Carey MP, Vanable PA: Methodological challenges in research on sexual risk behavior: II. Accuracy of self-reports. Ann Behav Med. 2003, 26: 104-10.1207\/S15324796ABM2602_03.","journal-title":"Ann Behav Med"},{"key":"28_CR19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1207\/S15324796ABM2602_03","volume":"26","author":"KE Schroder","year":"2003","unstructured":"Schroder KE, Carey MP, Vanable PA: Methodological challenges in research on sexual risk behavior: II. Accuracy of self-reports. Ann Behav Med. 2003, 26: 104-10.1207\/S15324796ABM2602_03.","journal-title":"Ann Behav Med"},{"key":"28_CR20","unstructured":"NHANES 2003\u20132004 Documentation: Syphilis (IgG), Syphilis Rapid Plasma Reagin (RPR), and Treponema pallidum Particle Agglutination (TP-PA). National Center for Health Statistics. 1-1-2006. 5-15-2006"},{"key":"28_CR21","unstructured":"NHANES 2003\u20132004 Documentation: Herpes I and Herpes II. National Center for Health Statistics. 1-1-2006. 5-15-2006"},{"key":"28_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/9781118032619","volume-title":"Analysis of Health Surveys","author":"E Korn","year":"1999","unstructured":"Korn E, Graubard B: Analysis of Health Surveys. 1999, New York: Wiley"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-9378-2-19.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:59:54Z","timestamp":1630457994000},"score":1,"resource":{"primary":{"URL":"https:\/\/infectagentscancer.biomedcentral.com\/articles\/10.1186\/1750-9378-2-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,24]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["28"],"URL":"https:\/\/doi.org\/10.1186\/1750-9378-2-19","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,24]]},"assertion":[{"value":"21 May 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"19"}}